This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Potgens, A. J. Articles by de Waal, R. M. Search for Related Content PubMed PubMed Citation Articles by Potgens, A. J. Articles by de Waal, R. M.

American Journal of Pathology, Vol 146, 197-209, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Vascular permeability factor expression influences tumor angiogenesis in human melanoma lines xenografted to nude mice

AJ Potgens, NH Lubsen, MC van Altena, JG Schoenmakers, DJ Ruiter and RM de Waal
Institute of Pathology, University Hospital Nijmegen, The Netherlands.

We studied the expression of the angiogenic factor vascular permeability factor) (VPF, also called vascular endothelial growth factor), in human melanoma cells in vitro and in vivo. Melanoma lines that develop tumors with a low metastatic potential in nude mice were found to have low expression levels of VPF in vitro, and the VPF expression levels in melanoma lines that yield highly metastatic xenografts were high. However, in vivo the correlation between VPF mRNA levels and the frequency of metastasis was lost; in all xenografts equally high levels of VPF mRNA were found, independent of the parental cell line. Hence, in vivo VPF gene expression was upregulated in the low expressing lines. The external factor responsible for this induction may be hypoxia, given that we found that low oxygen tension caused a (reversible) increase in the VPF mRNA levels in otherwise low expressing melanoma lines in vitro. A melanoma line with an inducible VPF expression was engineered into a line with a constitutive VPF expression. In the xenografts from this line a change in the vascular architecture was seen, indicating that the pattern or the level of VPF expression is important for tumor angiogenesis in melanoma xenografts.

This article has been cited by other articles:

				P. Wulfing, C. Kersting, J. Tio, R.-J. Fischer, C. Wulfing, C. Poremba, R. Diallo, W. Bocker, and L. Kiesel Endothelin-1-, Endothelin-A-, and Endothelin-B-Receptor Expression Is Correlated with Vascular Endothelial Growth Factor Expression and Angiogenesis in Breast Cancer Clin. Cancer Res., April 1, 2004; 10(7): 2393 - 2400. [Abstract] [Full Text] [PDF]

				R. Clarijs, I. Otte-Holler, D. J. Ruiter, and R. M. W. de Waal Presence of a Fluid-Conducting Meshwork in Xenografted Cutaneous and Primary Human Uveal Melanoma Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 912 - 918. [Abstract] [Full Text] [PDF]

				J. L. Yu, J. W. Rak, G. Klement, and R. S. Kerbel Vascular Endothelial Growth Factor Isoform Expression as a Determinant of Blood Vessel Patterning in Human Melanoma Xenografts Cancer Res., March 1, 2002; 62(6): 1838 - 1846. [Abstract] [Full Text] [PDF]

				U. Graeven, U. Rodeck, S. Karpinski, M. Jost, S. Philippou, and W. Schmiegel Modulation of Angiogenesis and Tumorigenicity of Human Melanocytic Cells by Vascular Endothelial Growth Factor and Basic Fibroblast Growth Factor Cancer Res., October 1, 2001; 61(19): 7282 - 7290. [Abstract] [Full Text] [PDF]

				E. K. Rofstad and E. F. Halsør Vascular Endothelial Growth Factor, Interleukin 8, Platelet-derived Endothelial Cell Growth Factor, and Basic Fibroblast Growth Factor Promote Angiogenesis and Metastasis in Human Melanoma Xenografts Cancer Res., September 1, 2000; 60(17): 4932 - 4938. [Abstract] [Full Text]

				J. Kishimoto, R. Ehama, Y. Ge, T. Kobayashi, T. Nishiyama, M. Detmar, and R. E. Burgeson In Vivo Detection of Human Vascular Endothelial Growth Factor Promoter Activity in Transgenic Mouse Skin Am. J. Pathol., July 1, 2000; 157(1): 103 - 110. [Abstract] [Full Text] [PDF]

				T. G Sheidow, P. L Hooper, C. Crukley, J. Young, and J G. Heathcote Expression of vascular endothelial growth factor in uveal melanoma and its correlation with metastasis Br. J. Ophthalmol., July 1, 2000; 84(7): 750 - 756. [Abstract] [Full Text]

				P. A. Pavco, K. S. Bouhana, A. M. Gallegos, A. Agrawal, K. S. Blanchard, S. L. Grimm, K. L. Jensen, L. E. Andrews, F. E. Wincott, P. A. Pitot, et al. Antitumor and Antimetastatic Activity of Ribozymes Targeting the Messenger RNA of Vascular Endothelial Growth Factor Receptors Clin. Cancer Res., May 1, 2000; 6(5): 2094 - 2103. [Abstract] [Full Text]

				R. Folberg, M. J. C. Hendrix, and A. J. Maniotis Vasculogenic Mimicry and Tumor Angiogenesis Am. J. Pathol., February 1, 2000; 156(2): 361 - 381. [Abstract] [Full Text] [PDF]

				A. Hartmann, M. Kunz, S. Kostlin, R. Gillitzer, A. Toksoy, E.-B. Brocker, and C. E. Klein Hypoxia-induced Up-Regulation of Angiogenin in Human Malignant Melanoma Cancer Res., April 1, 1999; 59(7): 1578 - 1583. [Abstract] [Full Text] [PDF]

				D. E. Clark, S. K. Smith, Y. He, K. A. Day, D. R. Licence, A. N. Corps, R. Lammoglia, and D. S. Charnock-Jones A Vascular Endothelial Growth Factor Antagonist Is Produced by the Human Placenta and Released into the Maternal Circulation Biol Reprod, December 1, 1998; 59(6): 1540 - 1548. [Abstract] [Full Text]

				R. O SCHLINGEMANN and V. W M VAN HINSBERGH Role of vascular permeability factor/vascular endothelial growth factor in eye disease Br. J. Ophthalmol., June 1, 1997; 81(6): 501 - 512. [Full Text] [PDF]